CA Patent

CA3069359C — Compositions comprising encapsulated tretinoin

Assigned to Sol Gel Technologies Ltd · Expires 2023-01-10 · 3y expired

What this patent protects

The present application is directed to compositions comprising microcapsules comprising encapsulated tretinoin, wherein the microcapsule size is less than 50 µm; and to methods of use thereof.

USPTO Abstract

The present application is directed to compositions comprising microcapsules comprising encapsulated tretinoin, wherein the microcapsule size is less than 50 µm; and to methods of use thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA3069359C
Jurisdiction
CA
Classification
—
Expires
2023-01-10
Drug substance claim
No
Drug product claim
No
Assignee
Sol Gel Technologies Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.